Invitrogen to Sell Facility to HGS in $55M Cash Deal | GenomeWeb

NEW YORK, March 9 - Invitrogen has sold its Rockville, Md., facility to Human Genome Sciences for $55 million in cash, the company said Friday.

Invitrogen acquired the 240,000 square foot facility in its September 2000 acquisition of Life Technologies, which had it headquarters located at the facility. Invitrogen occupies facilities in five other locations, including a manufacturing site in Frederick County, Md.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.